Qiming U.S. Healthcare
Startup rounds since 2014 with a Qiming U.S. Healthcare investor on the board, and the firm's own fund filings.
Raises
40
since 2014
Unannounced
2
no announcement found, of those filed since 2025
Funds
3
fund filings under the firm's name
Rounds
- Auron Therapeutics, Inc.$7.12M
- Entact Bio, Inc.$10M
- AirNexis Therapeutics, Inc.$62M
- Varo Money, Inc.$124M
- Auron Therapeutics, Inc.$27.3M
- Dualitas Therapeutics, Inc.$32.6M
- Renasant Bio, Inc.$30M
- Supira Medical, Inc.$120M
- Soda Health, Inc.$54.2M
- Boulder Care, Inc.$35M
- Entact Bio, Inc.$40.3M
- Soda Health, Inc.$9M
- Auron Therapeutics, Inc.$38.4M
- Boulder Care, Inc.$35.7M
- Platelet BioGenesis, Inc.$35.4M
- Cardialen, Inc.$4.38M
- Umoja Biopharma, Inc.$210M
- Icosavax, Inc.$99.7M
- WindMIL Therapeutics, Inc.$2.33M
- Auron Therapeutics, Inc.$15.4M
- Elevation Oncology, Inc.$65M
- Talaris Therapeutics, Inc.$115M
- Element Science, Inc.$50.6M
- Icosavax, Inc.$30M
- Platelet BioGenesis, Inc.$26.4M
- Nuvaira, Inc.$25M
- Dermira, Inc.$1M
- Amphivena Therapeutics, Inc.$38.7M
- Aimmune Therapeutics, Inc.$98M
- Aimmune Therapeutics, Inc.$157M
- Dermira, Inc.$500K
- Platelet BioGenesis, Inc.$10M
- Moximed, Inc$49.5M
- Ivantis, Inc.$25M
- Dermira, Inc.$1.5M
- Kona Medical, Inc.$10M
- Moximed, Inc$19.7M
- TWELVE, Inc.$35.2M
- Dermira, Inc.$51M
- Five Prime Therapeutics Inc$21M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 4 | 2 |
| 2025 | 4 | 0 |
| 2024 | 4 | — |
| 2023 | 1 | — |
| 2022 | 1 | — |
| 2021 | 5 | — |
| 2020 | 4 | — |
| 2019 | 3 | — |
| 2018 | 4 | — |
| 2017 | 4 | — |
| 2016 | 1 | — |
| 2015 | 3 | — |
| 2014 | 2 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Qiming U.S. Healthcare Fund III, L.P. | 21 Apr 2021 | $300M | — |
| Qiming U.S. Healthcare Fund II, L.P. | 30 Jan 2019 | $250M | — |
| Qiming U.S. Healthcare Fund, L.P. | 11 Jan 2017 | $125M | — |
Listed because a Qiming U.S. Healthcare fund's filing names a director of each company. A name match is not a verified identity.